Inclusion criteria | |
 • Healthy subjects of any sex and age | |
 • Fitzpatrick skin types I, II, or III (non-Hispanic, Caucasian ethnicity) | |
 • Non-dominant proximal anterior forearm is wide enough to ensure reproducible placement of light-emitting diode-red light (LED-RL) phototherapy or mock therapy hand-held unit | |
 • Available and willing to attend all clinic visits | |
 • Able and willing to give informed consent | |
Exclusion criteria | |
 • Subjects with Fitzpatrick skin types IV, V, or VI (ethnic groups) | |
 • Subjects on any photosensitizing medications (e.g., lithium, phenothiazine antipsychotics, and tetracycline antibiotics) | |
 • Subjects with light-sensitive conditions | |
 • Subjects with diabetes mellitus | |
 • Subjects with a history of melanoma and non-melanoma skin cancer | |
 • Subjects with systemic lupus erythematous | |
 • Subjects with open wounds on the non-dominant proximal anterior forearm | |
 • Subjects with fibrotic skin disease or other skin conditions on the non-dominant proximal anterior forearm | |
 • Subjects with tattoos that cover the procedure site on the non-dominant proximal anterior forearm | |
 • Subjects who previously participated in the phase 1 study of LED-RL in human skin (ClinicalTrials.gov Identifier: NCT02630303) |